Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Apr 4;12(1):e003050.
doi: 10.1136/openhrt-2024-003050.

Characteristics and prognosis in acute myocarditis and unexplained acute chest pain: a nationwide longitudinal cohort study

Marie Björkenstam  1   2 , Emanuele Bobbio  3   2 , Christian L Polte  2   4   5 , Clara Hjalmarsson  3   2 , Niklas Bergh  2 , Elmir Omerovic  3   2 , Entela Bollano  3   2
Affiliations
Multicenter Study

Characteristics and prognosis in acute myocarditis and unexplained acute chest pain: a nationwide longitudinal cohort study

Marie Björkenstam et al. Open Heart. .

Abstract

Aims: Acute myocarditis (AM) is a disease with variable prognosis, ranging from complete recovery to end-stage heart failure (HF) and death but often challenging to differentiate from unexplained acute chest pain (UCP) in the acute setting. This study examines the short-tem and long-term outcomes of AM compared with UCP, focusing on the risk of HF development.

Methods: We used the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies-registry to identify patients >16 years admitted to hospital between 1 January 1998 and 31 December 2018 with either AM or UCP. Patients were followed for outcomes including mortality, rehospitalisation and HF development over both short-term (30 days) and long-term periods. Cox proportional hazards models were used to compare the risks, adjusting for demographic and clinical-related factors.

Results: A total of 3792 patients with AM and 109 934 patients with UCP were included. Median follow-up time was 7.8 years (Q1, Q3; 3.4, 12.3). AM patients were younger compared with UCP patients, median age 37 years (Q1, Q3; 26, 52) vs 59 years (Q1, Q3; 49, 69) and more likely to be men (79.9% vs 51.4%, p<0.001). Comorbidity burden was less pronounced within the AM cohort. Chest pain was the most common presenting symptom in both groups. Mortality rate at 30 days (OR 3.75, 95% CI 1.9 to 7.3, p<0001) as well as long term (OR 2.0, 95% CI 1.69 to 2.39, p<0.001) were significantly higher in AM patients compared with UCP. AM patients were more likely to develop HF during follow-up (OR 2.3, 95% CI 1.81 to 2.93, p<0001).

Conclusions: AM is associated with worse short-term and long-term outcomes compared with UCP, including a higher risk of developing HF even after the first year.

Keywords: Chest Pain; HEART FAILURE; Myocarditis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. All-cause mortality for patients with acute myocarditis and acute unexplained chest pain at 30 days.
Figure 2
Figure 2. Percentage of patients hospitalised for suspected AM undergoing coronary angiography during 1999–2018. AM, acute myocarditis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cooper LT., Jr Myocarditis. N Engl J Med. 2009;360:1526–38. doi: 10.1056/NEJMra0800028. - DOI - PMC - PubMed
    1. Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48. doi: 10.1093/eurheartj/eht210. - DOI - PubMed
    1. Ammirati E, Cipriani M, Moro C, et al. Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry. Circulation. 2018;138:1088–99. doi: 10.1161/CIRCULATIONAHA.118.035319. - DOI - PubMed
    1. Ferone E, Segev A, Tempo E, et al. Current Treatment and Immunomodulation Strategies in Acute Myocarditis. J Cardiovasc Pharmacol. 2024;83:364–76. doi: 10.1097/FJC.0000000000001542. - DOI - PMC - PubMed
    1. Kytö V, Sipilä J, Rautava P. The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood. Heart. 2013;99:1681–4. doi: 10.1136/heartjnl-2013-304449. - DOI - PubMed

Publication types

MeSH terms